Sibeprenlimab Reduces Protein Levels in Adults with IgA Nephropathy shows Phase 3 VISIONARY study Medha Baranwal8 Nov 2024 8:15 PM ISTUSA: An interim analysis of the Phase 3 VISIONARY study revealed that sibeprenlimab achieved a significant and clinically meaningful reduction in the...
Incident Heart Failure Increases Risk of End-Stage Kidney Disease in Type 2 Diabetes Patients: Study finds Medha Baranwal27 Jun 2024 7:30 AM ISTSingapore: A recent study has uncovered concerning implications for individuals with type 2 diabetes who develop incident heart failure, revealing an...
Corticosteroids use reduces proteinuria but fails to delay ESKD in immunoglobulin A nephropathy: Study Medha Baranwal15 March 2024 8:45 PM ISTNorway: In a cohort of Norwegian patients with immunoglobulin A nephropathy (IgAN), a recent retrospective cohort study showed no impact of...
Bleeding complications common in ESKD patients undergoing atrial fibrillation ablation Dr Kartikeya Kohli30 March 2023 7:45 PM ISTJapan: A recent study suggests that international guideline recommendations for peri-procedural anticoagulation may not apply to end-stage kidney...
LRG1 predicts kidney disease progression in type 2 diabetes patients Dr Kartikeya Kohli17 March 2023 8:00 PM ISTSingapore: Diabetes is the leading cause of end-stage kidney disease (ESKD) in many countries (1). The pathophysiological mechanisms underlying the...
Wearable device improves daily step counts in hemodialysis patients with ESKD Jacinthlyn Sylvia6 March 2023 8:00 PM ISTThe results of a study published in the American Journal of Kidney Diseases demonstrates that a wearable activity tracker plus structured feedback...
Renal function deterioration among diabetes patients strongly linked to HF hospitalization Dr Kartikeya Kohli16 Nov 2022 10:15 AM ISTFRANCE: Beyond baseline eGFR, renal function deterioration was a major and independent risk factor linked to the development of heart failure...
Longer intervals between hemodialysis and surgery may increase risk of postoperative mortality in CKD: JAMA Jacinthlyn Sylvia13 Nov 2022 8:00 PM ISTA new study published in the Journal of American Medical Association shows that longer intervals between hemodialysis and surgery were substantially...
Discontinuing RAS inhibitors in advanced CKD doesn't slow decline in estimated GFR: NEJM Dr.Niharika Harsha B7 Nov 2022 8:00 PM ISTA new study found that discontinuation of Renin-angiotensin inhibitors in progressive and advanced end-stage kidney disease patients is not linked to...
Anemia and low estimated GFR risk factors for chronic kidney disease patients Dr.Niharika Harsha B27 Oct 2022 8:00 PM ISTNew research found that severe anemia, low iron levels, and low estimated glomerular filtration rates are the risk factors for chronic kidney disease...
GLP 1 Receptor Agonists to have better outcomes Than DPP4 Inhibitors Dr. Nandita Mohan14 March 2022 5:00 PM ISTA recent study suggests that the use of GLP-1 receptor agonists was associated with better outcomes compared with the use of DPP-4 inhibitors among...
GLP-1 Receptor Agonists Have better Outcomes Than DPP4 Inhibitors in T2D patients & CKD Dr Kartikeya Kohli10 March 2022 10:30 AM ISTChronic kidney disease (CKD) and end-stage kidney disease (ESKD) are contributors to the health burden and are associated with increased mortality and...
